Amazon S3 on MSN

Tricky mod phase 4 song complete! [Part 2]

Welcome back to Friday Night Funkin'. Being that I had no idea there was a secret fourth song titled Expurgation aka "Tricky Phase 4", I'm playing it in this video! It was very "unfair" but it's no ...
Business Insider

The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics’ Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II)

Tividenofusp alfa treatment showed reduction and normalization in key disease biomarkers, stabilization or improvement in clinical endpoints including adaptive behavior, cognition and hearing, and ...
Nasdaq

Monte Rosa To Present Updated Phase 1/2 Data For MRT-2359 In Prostate Cancer Today

(RTTNews) - Monte Rosa Therapeutics, Inc. (GLUE) today will present updated interim results from its ongoing Phase 1/2 study of MRT-2359 in patients with metastatic castration-resistant prostate ...
Hosted on MSN

Skeleton Tricky and Steve FNF Mod

VaporTheGamer reacts to skeleton tricky phase 5 and minecraft steve in friday night funkin'! (friday night mining/tricky 5) with fun commentary, unique insights, and FNAF or FNF fan excitement. Alina ...
Seeking Alpha

Intensity Therapeutics surges 395% on phase 1/2 data for solid tumors asset

Intensity Therapeutics (INTS), with a ~$13M market cap, closed up nearly 395% Thursday after publishing phase 1/2 results on its candidate for metastatic or refractory cancers, INT230-6. The asset ...
Healio

AURN001 cell therapy achieves primary endpoint of visual acuity improvement at 12 months

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The allogenic cell therapy achieved all primary and ...
contemporarypediatrics

Regeneron’s DB-OTO shows sustained hearing recovery in phase 1/2 CHORD trial

In a recent trial, 11 of 12 children treated with DB-OTO demonstrated meaningful hearing gains. New data from the Phase 1/2 CHORD trial published in The New England Journal of Medicine and presented ...
ophthalmologytimes

ASRS 2025: Phase 1/2 study update on OCU-410 for geographic atrophy

Jay Chhablani, MD, presented the phase 1/2 clinical trial data for OCU410, at the 2025 annual meeting of the American Society of Retina Specialists. Jay Chhablani, MD, Vice Chair at the University of ...
Superhero Hype

Marvel Phase 1, 2 & 3 Heroes Who May Not Be Recast After Avengers: Secret Wars

Excited to know which Marvel heroes may not be recast after Avengers: Secret Wars? For those unaware, Kevin Feige, president of Marvel Studios, announced that Secret Wars will mark the new beginning ...
ophthalmologytimes

Krystal Biotech doses first patient in EMERALD-1 phase 1/2 trial for neurotrophic keratitis

EMERALD-1 trial evaluates KB801, a gene therapy for neurotrophic keratitis, focusing on safety and efficacy in corneal healing. KB801 aims to sustain NGF expression in the eye, potentially reducing ...
Nasdaq

Krystal Biotech Initiates First Patient Dosing in Phase 1/2 EMERALD-1 Trial for KB801 in Neurotrophic Keratitis

Krystal Biotech, Inc. announced the dosing of the first patient in its Phase 1/2 clinical trial, EMERALD-1, which is evaluating KB801, an eye drop gene therapy for neurotrophic keratitis (NK), a rare ...